Incyte Corporation

Healthcare
$57.12
+0.57(1.01%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Open PricePrev. CloseVolumeAvg. Volume
$56.52$57.125431,754,905

Fundamentals

Market Cap$12.82B
P/B Ratio2.5
P/E Ratio21.5
Enterprise Value$9.64B
Div. Yield0.00%
Book Value22.01
EPS(TTM)0.76
ROENA
Understand Fundamentals

About the Company

Incyte Corp is a Wilmington, Delaware based biopharmaceutical company with an extensive global presence. With approximately 1,500 employees, the company has operations in the United States, Japan and Europe. With expertise in medicinal chemistry and biology, Incyte develops products, helmed by world-class scientists. The company produces medicines under two franchises - Inflammation & Autoimmunity and Oncology. However, it develops medicines for four therapeutic areas, namely Immunology, Oncology, Rheumatology and Dermatology. As of 2020, it has 19 molecular targets and 22 clinical candidates it is working upon. Some of its medicines are Jakafi, INCB00928, INCB86550, Pemigatinib, Iclusig, Pemazyre, Monjuvi, Tabrecta, Olumiant, etc. The molecules it is developing for its drugs include FGFR, JAK, ARG, GITR, LAG-3, PI3Kδ, PD-1/PD-L1, TIM-3, etc. Between 2009 and 2020, Incyte has collaborated with ten companies, producing medicines like capmatinib20, Tabrecta, baricitinib17 and Olumiant. Few of the notable companies it has partnered with are Eli Lilly and Company, Agenus Inc., MacroGenics Inc., MorphoSys AG, Novartis International Pharmaceutical Ltd., Zai Lab, Ltd., Merus N.V., Innovent Biologics, Inc., ARIAD Pharmaceuticals, Inc. and Calithera Biosciences, Inc. Incyte was formed in 2002 by a group of scientists, biologists and chemists who were working in immunology. As of 2020, it is an S&P 500 component as well as a NASDAQ 100 component. It trades in the NASDAQ stock exchange under the ticker symbol INCY. It holds the 953rd rank in the 2020 Fortune 1000 list of companies. In the same year, it made into the Forbes list of Global 2000 companies. In 2018, it was the 7th most innovative company in the world, according to Forbes rankings.;
OrganisationIncyte Corporation
IndustryBiotechnology
HeadQuartersWilmington, DE

Company Financials

*All values are in Million $
No Graph Data To Display
Quarterly
Yearly

Similar Stocks

COMPANYMARKET PRICECLOSE PRICEMARKET CAP
Invest the way you want
Join millions of Indians who trust and love Groww
Explore Products
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ